Download Files:
HNMPA
SKU
HY-101962-10 mg
Category Reference compound
Tags Insulin Receptor, Metabolic Disease, Protein Tyrosine Kinase/RTK
Products Details
Product Description
– HNMPA is a membrane impermeable insulin receptor tyrosine kinase inhibitor. HNMPA inhibits serine and tyrosine autophosphorylation by the human insulin receptor. HNMPA has no effect on protein kinase C or cyclic AMP-dependent protein kinase activities[1][2]
Web ID
– HY-101962
Shipping
– Room temperature
Molecular Formula
– C11H11O4P
References
– [1]K Baltensperger, et al. Catalysis of serine and tyrosine autophosphorylation by the human insulin receptor. Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):7885-9.|[2]Peter Kovacs, et al. In vivo electrophysiological effects of insulin in the rat brain. Neuropeptides. 2009 Aug;43(4):283-93.
CAS Number
– 132541-52-7
Molecular Weight
– 238.18
SMILES
– OC(P(O)(O)=O)C1=CC=C2C=CC=CC2=C1
Clinical Information
– No Development Reported
Research Area
– Metabolic Disease
Solubility
– 10 mM in DMSO
Target
– Insulin Receptor
Pathway
– Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.